New drug cocktail aims to halt aggressive breast cancer
Disease control
ENROLLING_BY_INVITATION
This study tests a combination of two drugs, sacituzumab govitecan and bevacizumab, in people with metastatic triple-negative breast cancer that has progressed after at least one prior treatment. The trial will enroll 60 participants across several centers in China. Researchers w…
Phase: PHASE2 • Sponsor: YING FAN • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC